BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19234509)

  • 1. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Ambruzova Z; Mrazek F; Raida L; Jindra P; Vidan-Jeras B; Faber E; Pretnar J; Indrak K; Petrek M
    Bone Marrow Transplant; 2009 Aug; 44(4):227-35. PubMed ID: 19234509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
    Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IL-6 gene polymorphism with the outcome of allogeneic haematopoietic stem cell transplantation in Czech patients.
    Ambruzova Z; Mrazek F; Raida L; Faber E; Onderkova J; Kriegova E; Indrak K; Petrek M
    Int J Immunogenet; 2008 Aug; 35(4-5):401-3. PubMed ID: 18976446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation.
    Ambruzova Z; Mrazek F; Raida L; Stahelova A; Faber E; Indrak K; Petrek M
    Hum Immunol; 2009 Jun; 70(6):457-60. PubMed ID: 19286444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
    Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
    Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
    Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
    van der Velden WJ; Blijlevens NM; Maas FM; Schaap NP; Jansen JH; van der Reijden BA; Feuth T; Dolstra H; Donnelly JP
    Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
    Holler E; Rogler G; Brenmoehl J; Hahn J; Greinix H; Dickinson AM; Socie G; Wolff D; Finke J; Fischer G; Jackson G; Rocha V; Hilgendorf I; Eissner G; Marienhagen J; Andreesen R
    Int J Immunogenet; 2008 Aug; 35(4-5):381-4. PubMed ID: 18976442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bogunia-Kubik K; Duda D; Suchnicki K; Lange A
    Haematologica; 2006 Dec; 91(12):1628-34. PubMed ID: 17145599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Middleton P; Norden J; Dickinson A; Lange A
    Int J Immunogenet; 2008 Jun; 35(3):207-13. PubMed ID: 18312595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
    Bertinetto FE; Dall'Omo AM; Mazzola GA; Rendine S; Berrino M; Bertola L; Magistroni P; Caropreso P; Falda M; Locatelli F; Busca A; Amoroso A
    Int J Immunogenet; 2006 Oct; 33(5):375-84. PubMed ID: 16984283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
    Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
    Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease.
    Kim DH; Lee NY; Lee MH; Sohn SK
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1408-16. PubMed ID: 19041064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.